| |
| |
|
| Insider
Information: |
Pacelli Steven Robert |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
142,975 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,819,527 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,975 |
|
|
| Total
Value |
$14,819,527 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 44.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
EVP Managing Director ... |
2023-11-24 |
124,775 |
2008-11-19 |
0 |
Premium* |
|
|
Prosomnus, Inc. |
OSA |
|
2022-12-06 |
18,200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
216 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2017-07-24 |
4 |
AS |
$69.47 |
$100,725 |
D/D |
(1,450) |
112,074 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2017-08-23 |
4 |
AS |
$75.26 |
$300,045 |
D/D |
(3,987) |
108,087 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2017-09-11 |
4 |
D |
$71.81 |
$525,028 |
D/D |
(7,311) |
100,776 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2017-09-25 |
4 |
AS |
$69.81 |
$101,219 |
D/D |
(1,450) |
99,326 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2017-11-29 |
4 |
AS |
$60.12 |
$174,340 |
D/D |
(2,900) |
96,426 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-03-08 |
4 |
A |
$0.00 |
$39 |
D/D |
38,502 |
134,928 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-03-12 |
4 |
D |
$60.73 |
$552,527 |
D/D |
(9,098) |
125,830 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-05-10 |
4 |
OE |
$7.63 |
$21,784 |
D/D |
2,855 |
128,685 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-07-25 |
4 |
AS |
$101.46 |
$317,335 |
D/D |
(3,114) |
125,571 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-08-23 |
4 |
AS |
$139.66 |
$435,843 |
D/D |
(3,114) |
122,457 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-09-10 |
4 |
S |
$143.76 |
$788,210 |
D/D |
(5,483) |
116,974 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-09-24 |
4 |
AS |
$138.69 |
$439,841 |
D/D |
(3,114) |
113,860 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-10-23 |
4 |
AS |
$128.61 |
$401,253 |
D/D |
(3,114) |
110,746 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-11-23 |
4 |
AS |
$119.82 |
$378,105 |
D/D |
(3,114) |
107,632 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2018-12-21 |
4 |
AS |
$108.24 |
$340,700 |
D/D |
(3,114) |
104,518 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Strategy & Corp. Dev. |
• – – |
2019-01-23 |
4 |
AS |
$149.74 |
$466,303 |
D/D |
(3,114) |
101,404 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-02-22 |
4 |
AS |
$140.50 |
$241,157 |
D/D |
(1,667) |
99,737 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$15 |
D/D |
14,987 |
114,724 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-03-12 |
4 |
S |
$142.79 |
$1,543,726 |
D/D |
(10,811) |
103,913 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-03-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
350 |
103,563 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-03-22 |
4 |
AS |
$139.77 |
$503,571 |
D/D |
(3,596) |
99,967 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-04-23 |
4 |
AS |
$116.27 |
$419,329 |
D/D |
(3,596) |
96,371 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-05-23 |
4 |
AS |
$116.01 |
$419,816 |
D/D |
(3,597) |
92,774 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-06-24 |
4 |
AS |
$148.85 |
$466,304 |
D/D |
(3,116) |
89,658 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-09-09 |
4 |
S |
$145.46 |
$875,620 |
D/D |
(5,843) |
83,815 |
0 |
- |
|
216 Records found
|
|
Page 6 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
